Northwest Bio's CEO made out well

There’s not a ton new to say about Northwest Biotherapeutics these days, as its brain tumor vaccine has been largely forgotten and its stock price is now next to nil. But STAT’s Adam Feuerstein found a juicy little detail in a regulatory filing, showing how Northwest’s top executive made a pretty penny at the expense of its shareholders. 

CEO Linda Powers loaned millions of dollars to the cash-strapped biotech last year at "terms that would make a predatory payday lender blush." Then the company, which is trading at about a quarter a share, raised $4 million in its second quarter — and promptly wrote a check for $4.7 million to Powers.

Read more.